ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Fitzgerald Kevin Joseph โ CSO & EVP, Head of Research
Shares
158
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 12, 2026
EPS:0.82 (est: 1.16)-29.3%
Revenue:$1.10B (est: $1.15B)-4.5%
Transaction Details
| Insider | Fitzgerald Kevin Joseph |
|---|---|
| Title | CSO & EVP, Head of Research |
| Transaction Date | Feb 23, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 25, 2026 |
| Shares Purchased | 158 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 21,422 |
| Derivative | No |
| Accession Number | 0001735276-26-000032 |
| Document | View SEC Filing |